Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:40 PM
Ignite Modification Date:
2025-12-24 @ 6:40 PM
NCT ID:
NCT03136757
Eligibility Criteria:
Inclusion Criteria:
* Person aged ≥ 18 years
* Patients who have received an HSC allograft since June 2012
* Having presented a suspicion of cutaneous or digestive GVHD before J100 post-allograft
* Of which the diagnosis was retained by the combination of clinical and histological criteria
* Or whose diagnosis has been reversed by histological analysis, for the reactive / inflammatory biopsies that serve as control
* The diagnosis of which was made between 01/01/2013 and 31/12/2015
* Survived at least 1 month to monitor clinical progress
Exclusion Criteria:
* Whose biopsy specimens were also the sites of a viral reactivation (EBV, CMV, HHV) that could mimic a GVHD
* Having survived less than 1 month after the diagnosis of GVHD
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03136757
Study Brief:
Protocol Section:
NCT03136757